Study Information
Study Details
View study details on clinicaltrials.gov.
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Location: REDI (East Bay)
Please contact: Yomi Kapasi about the following study:
The LOU study
"A Randomized, Double-blind, Double-dummy, Parallel-group Study, Comparing the Efficacy and Safety of Remibrutinib Versus Teriflunomide in Participants With Relapsing Multiple Sclerosis, Followed by Extended Treatment With Open-label Remibrutinib"
Principal Investigator
Co-Investigator(s)
Lynn Jehle, NP, Bradley T Wrubel, MD, Joanna A. Cooper, M.D., Matthew W. Arnold, M.D.
Related Studies
GXCA
Investigator: Lawrence Dickinson, M.D
Using Electronic Health Records to Identify Gaps in Migraine Headache Care: A Step Towards Improving Patient Outcomes
Mindfulness and Migraine: A Randomized Controlled Trial
Investigator: Sylvia Sudat, PhD